Results 11 to 20 of about 124,817 (274)
Calcitonin negative Medullary Thyroid Carcinoma: a challenging diagnosis or a medical dilemma?
BMC Endocrine Disorders, 2019 Background Medullary thyroid carcinoma is a neuroendocrine tumor belonging form a malignant growth of the thyroid parafollicular C-cells, representing from 1 to 10% of all thyroid cancer.
Claudio Gambardella +12 more
doaj +2 more sources
The International Journal of Biological Markers, 2018 Aim: Due to the limits of calcitonin, other markers are warranted to better manage medullary thyroid carcinoma patients, and procalcitonin has been reported as promising.
Pierpaolo Trimboli +6 more
doaj +2 more sources
BMC Endocrine Disorders, 2019 Background Medullary thyroid carcinoma is a malignant uncommon and aggressive tumour of the parafollicular C cells. In about 75% of cases it is sporadic while, in case of RET mutation, it is associated to multiple endocrine neoplasia type 2 (25% of cases)
Claudio Gambardella +11 more
doaj +2 more sources
Detection rate of FNA cytology in medullary thyroid carcinoma. a meta-analysis [PDF]
Clinical Endocrinology, 2015 Background: The early detection of medullary thyroid carcinoma (MTC) can improve patient prognosis, because histological stage and patient age at diagnosis are highly relevant prognostic factors. As a consequence, delay in the diagnosis and/or incomplete
Anna, Crescenzi +10 more
core +2 more sources
Journal of Clinical Oncology, 2021 PURPOSE Medullary thyroid carcinoma (MTC) is an aggressive neuroendocrine tumor (NET) arising from the calcitonin-producing C cells. Unlike other NETs, there is no widely accepted pathologic grading scheme.
Bin Xu +26 more
semanticscholar +1 more source
Integrated proteogenomic characterization of medullary thyroid carcinoma
Cell Discovery, 2022 Medullary thyroid carcinoma (MTC) is a rare neuroendocrine malignancy derived from parafollicular cells (C cells) of the thyroid. Here we presented a comprehensive multi-omics landscape of 102 MTCs through whole-exome sequencing, RNA sequencing, DNA ...
Xiao Shi +36 more
semanticscholar +1 more source
Sporadic Medullary Thyroid Carcinoma: Towards a Precision Medicine
Frontiers in Endocrinology, 2022 Medullary thyroid carcinoma (MTC) is a neuroendocrine malignant tumor originating from parafollicular C-cells producing calcitonin. Most of cases (75%) are sporadic while the remaining (25%) are hereditary.
A. Matrone +3 more
semanticscholar +1 more source
Current Guidelines for Management of Medullary Thyroid Carcinoma
Endocrinology and Metabolism, 2021 Medullary thyroid carcinoma (MTC) is a rare neuroendocrine tumor originating from the parafollicular cells. The diagnostic and therapeutic strategies for the condition are different from those used for well-differentiated thyroid cancer.
Mijin Kim, B. Kim
semanticscholar +1 more source
UNUSUAL PRESENTATION OF A THYROID MALIGNANCY: A CASE REPORT
National Journal of Medical Research, 2022 Medullary thyroid carcinoma is a rare malignancy. We report a case of Medullary thyroid carcinoma in a 56-year-old male patient. Patient presented with lower limb paresis and severe hypokalemia.
Lakshmi S Sunkara +3 more
doaj +1 more source
Cytopathologic analysis of thyroid secondary tumors [PDF]
Zhenduanxue lilun yu shijian, 2023 Objective: To observe the cytological pathological features of secondary thyroid neoplasm (STN) by ultrasound-guided fine-needle aspiration（FNA）. Methods: A total of 5023 cases of thyroid malignancy diagnosed by FNA cytology in The First Affiliated ...
YANG Qiao, FU Xin, WANG Zhe, LIU Tantan
doaj +1 more source